fda warning letter hims compounded semaglutide 2025 Takes Aim at & Hers, Weight-Loss Drugs in New Advertising Blitz FDA and Novo Nordisk Warned
Description
Peripheral administration of exendin-4 or liraglutide increase circulating corticosterone in mice under basal conditions and also during a forced swimming test [818]
Retatrutide itself is a peptide compound that, as of 2026, has not been granted full marketing authorisation as a licensed medicine in the UK
The medication is well-studied with extensive long-term data supporting both its efficacy and safety profile
Currently, the highest Wegovy dose available through Phlo Clinic is 2.4mg
Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR
